What this quiz covers
This quiz focuses on 1d Fatty Acid Protein Metabolism, giving you a quick way to practice the rules, question types, and explanations that matter most for MCAT Biological and Biochemical Foundations of Living Systems.
A patient with exercise intolerance is found to carry a homozygous missense variant in the gene encoding medium-chain acyl-CoA dehydrogenase (MCAD), a mitochondrial enzyme used during beta-oxidation of medium-chain fatty acids. During a supervised 18-hour fast, plasma measurements were obtained.
Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
MCAT Biological and Biochemical Foundations of Living Systems Quiz
Practice 1d Fatty Acid Protein Metabolism in MCAT Biological and Biochemical Foundations of Living Systems with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
This quiz focuses on 1d Fatty Acid Protein Metabolism, giving you a quick way to practice the rules, question types, and explanations that matter most for MCAT Biological and Biochemical Foundations of Living Systems.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
A patient with exercise intolerance is found to carry a homozygous missense variant in the gene encoding medium-chain acyl-CoA dehydrogenase (MCAD), a mitochondrial enzyme used during beta-oxidation of medium-chain fatty acids. During a supervised 18-hour fast, plasma measurements were obtained.
Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
Explanation: This question tests understanding of beta-oxidation defects and their metabolic consequences during fasting. MCAD catalyzes the first dehydrogenation step in beta-oxidation of medium-chain fatty acids, and its deficiency impairs the breakdown of these fatty acids into acetyl-CoA. During fasting, reduced acetyl-CoA production from beta-oxidation leads to decreased ketone body synthesis in the liver, forcing increased reliance on glucose for energy. The correct answer A accurately describes this metabolic shift with reduced ketogenesis and increased glucose utilization. Choice B incorrectly suggests increased ketone production, which is impossible when beta-oxidation is impaired since acetyl-CoA is the substrate for ketogenesis. When evaluating metabolic defects, trace the pathway from substrate to product to predict downstream effects.
A patient has a mutation that reduces activity of medium-chain acyl-CoA dehydrogenase (MCAD). During an overnight fast, plasma acylcarnitine profiling shows elevated medium-chain acylcarnitines, while urinary ketones are low despite hypoglycemia.
Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
Explanation: This question tests understanding of fatty acid metabolism, specifically medium-chain acyl-CoA dehydrogenase (MCAD) deficiency's effect on β-oxidation and ketogenesis. MCAD is crucial for mitochondrial β-oxidation of medium-chain fatty acids, producing acetyl-CoA for ketogenesis during fasting. The mutation leads to elevated acylcarnitines, low urinary ketones, and hypoglycemia, indicating blocked oxidation and reduced ketone production. Choice A is correct because impaired β-oxidation limits acetyl-CoA for ketogenesis, causing hypoketotic hypoglycemia. Choice B is incorrect as it suggests enhanced peroxisomal oxidation increasing ketones, but MCAD is mitochondrial and deficiency reduces overall oxidation. In similar inborn error cases, link enzyme defect to substrate accumulation and downstream fuel shortages. Check for compensatory pathways like peroxisomal oxidation but note their limitations.
Investigators measure initial velocity of purified human alanine aminotransferase (ALT) at varying alanine concentrations with b1-ketoglutarate held constant. NADH-coupled detection is used to quantify pyruvate formation. Initial rates plateau at high alanine.
Data (alanine, mM b2 v0, bcM/min): 0.2 b2 8 0.5 b2 18 1.0 b2 30 2.0 b2 40 5.0 b2 46
Which outcome is most consistent with the data on enzyme activity?
Explanation: This question tests understanding of protein metabolism, focusing on enzyme kinetics in amino acid transamination by alanine aminotransferase (ALT). ALT catalyzes the reversible transfer of an amino group from alanine to α-ketoglutarate, producing pyruvate and glutamate, following Michaelis-Menten kinetics with saturation at high substrate levels. The data show initial velocity plateauing at higher alanine concentrations with fixed α-ketoglutarate, indicating enzyme saturation. Choice D is correct because ALT becomes saturated near 5 mM alanine, so further increases yield minimal changes in v0, consistent with saturable kinetics. Choice B is incorrect as it assumes non-saturable, linear kinetics, ignoring the enzyme's finite active sites and typical hyperbolic behavior. For similar kinetics problems, plot or visualize the data to check for hyperbolic saturation and recall that enzymes approach Vmax at high substrate. Also, distinguish between substrates to identify which is variable and potentially limiting.
In a human study, insulin is infused while maintaining euglycemia. Liver biopsies (obtained for clinical reasons) show increased acetyl-CoA carboxylase (ACC) activity and increased malonyl-CoA concentration compared with pre-infusion. Plasma ketone bodies decrease.
What conclusion can be drawn about the role of insulin in fat storage?
Explanation: This question tests understanding of fatty acid metabolism, particularly insulin's regulation of lipogenesis and ketogenesis via malonyl-CoA. Insulin activates acetyl-CoA carboxylase (ACC), increasing malonyl-CoA, which inhibits CPT1 and mitochondrial fatty acid oxidation, reducing ketogenesis. Biopsies show increased ACC and malonyl-CoA with decreased plasma ketones, aligning with insulin's suppression of oxidation. Choice D is correct as elevated malonyl-CoA reduces fatty acid entry and ketogenesis, favoring storage. Choice B is incorrect because insulin increases, not decreases, malonyl-CoA, inhibiting CPT1. For regulatory studies, trace hormone effects on intermediates like malonyl-CoA and correlate with outcomes like ketone levels. Distinguish between acute and chronic insulin effects on liver metabolism.
An enzyme kinetics experiment measures initial velocity of glutamate dehydrogenase (GDH) in isolated human liver mitochondria while varying glutamate concentration; NAD+ is saturating. Ammonia production is quantified.
Data (glutamate, mM b2 v0, nmol NH3/min): 0.5 b2 12 1.0 b2 20 2.0 b2 30 4.0 b2 36 8.0 b2 39
Which outcome is most consistent with the data on enzyme activity?
Explanation: This question tests understanding of protein metabolism, focusing on kinetics of glutamate dehydrogenase (GDH) in amino acid catabolism. GDH catalyzes oxidative deamination of glutamate to α-ketoglutarate and ammonia, exhibiting saturable kinetics with respect to glutamate. The data show v0 increasing but plateauing at higher glutamate, consistent with Michaelis-Menten behavior. Choice D is correct as GDH approaches maximum rate at high substrate, yielding diminishing v0 increases. Choice B is incorrect because glutamate is the substrate, not product, so high levels drive forward reaction. For mitochondrial enzyme kinetics, ensure cofactors like NAD+ are saturating and monitor appropriate products. Recall GDH's role linking amino acid and carbohydrate metabolism.
A lab deprives cells of phenylalanine for 6 hours and measures secretion of a phenylalanine-rich plasma protein from hepatocytes. Intracellular mRNA levels for the protein are unchanged, but secreted protein decreases to 55% of control.
Which interpretation best explains the data?
Explanation: This question tests understanding of protein metabolism, focusing on phenylalanine deprivation's impact on secretion of phenylalanine-rich proteins. Deprivation limits translation of proteins requiring phenylalanine, reducing secretion without affecting mRNA levels. Decreased secreted protein despite stable mRNA indicates translational bottleneck. Choice A is correct because amino acid limitation reduces translation efficiency for dependent proteins. Choice C is incorrect as phenylalanine isn't required for transcription; effect is post-transcriptional. For secretion studies, compare mRNA and protein levels to localize effects. Note essential amino acids' roles in limiting synthesis of specific proteins.
A patient has recurrent fasting intolerance. Whole-exome sequencing identifies a variant that increases malonyl-CoA levels in liver by constitutively activating acetyl-CoA carboxylase (ACC). During fasting, plasma ketones are low despite elevated FFAs.
Based on the experimental setup, what is the most likely effect of this alteration on metabolism?
Explanation: This question tests understanding of fatty acid metabolism, particularly elevated malonyl-CoA's effect on ketogenesis. Malonyl-CoA inhibits CPT1, reducing mitochondrial fatty acid entry and β-oxidation, leading to low ketones despite high FFAs in fasting. The variant constitutively activates ACC, raising malonyl-CoA and causing fasting intolerance with hypoketosis. Choice A is correct as elevated malonyl-CoA inhibits entry, reducing oxidation and ketogenesis. Choice B is incorrect because malonyl-CoA inhibits, not activates, CPT1. For regulatory variants, predict effects on downstream pathways like oxidation. Correlate with clinical symptoms like fasting intolerance to confirm.
A patient with episodic rhabdomyolysis is found to have a mutation reducing muscle carnitine uptake (systemic carnitine deficiency). During prolonged exercise, plasma shows elevated long-chain acylcarnitines are low, while long-chain acyl-CoA accumulates in muscle biopsy.
Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
Explanation: This question tests understanding of fatty acid metabolism, specifically carnitine deficiency's impact on muscle β-oxidation during exercise. Carnitine is required for long-chain fatty acid transport into mitochondria via CPT systems; deficiency limits this, reducing ATP from oxidation and causing acyl-CoA accumulation. Elevated plasma acylcarnitines and muscle acyl-CoA during exercise indicate blocked transport and impaired energy production. Choice C is correct because reduced carnitine limits mitochondrial entry, decreasing β-oxidation and ATP. Choice B is incorrect as it suggests increased import and ketones, opposite to deficiency effects. In transport defect cases, look for substrate accumulation patterns to confirm blockade. Consider tissue-specific effects, like muscle fatigue in exercise.
A team examines the effect of leucine deprivation on protein synthesis in human skeletal muscle cells. Cells are incubated for 4 hours in complete media or leucine-free media. ATP levels remain stable, but phosphorylation of eIF2b1 (a translation initiation regulator) increases in leucine-free conditions.
Measured outcome: global protein synthesis (normalized)
Which interpretation best explains the reduction in protein synthesis?
Explanation: This question tests understanding of protein metabolism, particularly how leucine deprivation affects translation regulation. Leucine, an essential amino acid, signals through mTOR to promote translation initiation; its absence increases eIF2α phosphorylation, suppressing global protein synthesis. In leucine-free media, synthesis decreases with elevated eIF2α phosphorylation and stable ATP, indicating regulatory inhibition. Choice A is correct because amino acid limitation triggers signaling that suppresses translation, reducing synthesis. Choice C is incorrect as leucine is essential and cannot be synthesized de novo in humans. To evaluate similar deprivations, check signaling markers like eIF2α and energy levels to pinpoint mechanisms. Differentiate essential from nonessential amino acids in human metabolism.
To probe how amino acid availability constrains protein synthesis, researchers cultured primary human myotubes for 6 hours in complete medium or medium lacking leucine. They then added puromycin for 10 minutes and quantified puromycin incorporation into nascent polypeptides (a proxy for translation rate). Total cellular mRNA levels for a housekeeping gene were unchanged between conditions.
Which outcome is most consistent with the data on enzyme activity (translation machinery function) under leucine deprivation?
Explanation: This question tests understanding of protein metabolism regulation, specifically how amino acid availability controls translation through charged tRNA levels. Leucine is an essential amino acid that must be attached to its cognate tRNA by leucyl-tRNA synthetase for incorporation during translation elongation. When leucine is depleted, the pool of charged Leu-tRNA decreases, causing ribosomes to stall at leucine codons during elongation, thereby reducing overall translation rate despite unchanged mRNA levels. Puromycin incorporation serves as a readout for active translation because it mimics aminoacyl-tRNA and terminates growing peptide chains. Choice A is incorrect because amino acid deprivation typically suppresses, not stimulates, global translation through mechanisms like GCN2 kinase activation and eIF2α phosphorylation. To assess translation regulation, distinguish between changes in mRNA abundance versus ribosome activity, and remember that amino acid availability affects elongation through charged tRNA pools.
In a study of human skeletal muscle homogenates, investigators measured carnitine palmitoyltransferase I (CPT1) activity by tracking formation of palmitoylcarnitine from palmitoyl-CoA. Reactions were run at fixed enzyme concentration with increasing palmitoyl-CoA, either without malonyl-CoA or with 10 µM malonyl-CoA (a physiologic inhibitor during the fed state). Initial rates were recorded over the first 60 seconds.
Which outcome is most consistent with the data on enzyme activity?
Explanation: This question tests understanding of enzyme kinetics and regulation of fatty acid metabolism, specifically how malonyl-CoA inhibits CPT1. CPT1 catalyzes the rate-limiting step of fatty acid oxidation by converting fatty acyl-CoA to acylcarnitine for mitochondrial entry. Malonyl-CoA acts as a competitive inhibitor of CPT1, competing with palmitoyl-CoA for the active site, which increases the apparent Km (decreases affinity) without changing Vmax. The correct answer B accurately describes this competitive inhibition pattern where the substrate-rate curve shifts rightward. Choice A incorrectly suggests malonyl-CoA increases Vmax, which would indicate activation rather than inhibition. To identify competitive inhibition, look for increased Km with unchanged Vmax when inhibitor is present.
Researchers cultured human hepatocytes in media containing either all essential amino acids (control) or media lacking only leucine. Cells were then exposed to a fixed insulin concentration and pulsed with labeled methionine for 20 minutes to estimate global protein synthesis. ATP levels and cell viability were unchanged between conditions.
Which outcome is most consistent with the data on protein synthesis under leucine deficiency?
Explanation: This question tests understanding of essential amino acid requirements for protein synthesis. Leucine is an essential amino acid that cannot be synthesized by human cells and must be obtained from the diet. During translation, the absence of leucine causes ribosomes to stall at leucine codons because leucyl-tRNA cannot be formed, halting elongation despite adequate ATP and other resources. The correct answer C accurately describes this translation block at leucine codons. Choice B incorrectly claims leucine can be synthesized from acetyl-CoA, which is impossible in humans as we lack the necessary biosynthetic enzymes for branched-chain amino acids. Remember that essential amino acids create absolute requirements for protein synthesis that cannot be bypassed.
To probe protein catabolism during prolonged fasting, investigators measured urea nitrogen production in healthy adults before and after administration of a drug that inhibits hepatic transaminases (but does not affect renal clearance). Participants were kept on the same caloric restriction protocol throughout.
Which outcome is most consistent with inhibiting transamination during fasting?
Explanation: This question tests understanding of amino acid catabolism and urea cycle regulation during fasting. Transaminases catalyze the transfer of amino groups from amino acids to α-ketoglutarate, producing glutamate which can then be deaminated to release ammonia for urea synthesis. Inhibiting transaminases blocks this initial step of amino acid catabolism, reducing the flow of nitrogen into the urea cycle and decreasing urea production during protein breakdown in fasting. The correct answer D accurately describes this reduction in urea synthesis. Choice B incorrectly suggests transaminases consume ammonia, when they actually facilitate its eventual release through the glutamate dehydrogenase reaction. To trace nitrogen flow, follow amino groups from proteins through transamination to deamination to urea.
In an ex vivo assay, human adipose tissue slices were incubated with either epinephrine alone or epinephrine plus insulin. Glycerol release into the medium over 30 minutes was used as a proxy for triglyceride breakdown. Tissue mass and perfusion were equivalent across conditions.
What conclusion can be drawn about the role of insulin in fat storage?
Explanation: This question tests understanding of hormonal cross-talk in adipose tissue lipolysis regulation. Epinephrine stimulates lipolysis through β-adrenergic receptors, activating PKA to phosphorylate and activate hormone-sensitive lipase, leading to triglyceride breakdown and glycerol release. Insulin opposes this effect by activating phosphodiesterase and phosphatases, reducing PKA activity and HSL phosphorylation, thereby attenuating epinephrine-stimulated lipolysis. The correct answer B accurately describes insulin's anti-lipolytic effect even in the presence of epinephrine. Choice A incorrectly suggests insulin enhances lipolysis, which contradicts insulin's fundamental role in promoting storage and opposing catabolism. Remember that insulin generally opposes catabolic signals to maintain energy storage.
A newborn is diagnosed with primary carnitine deficiency due to impaired uptake of carnitine into cells. During an intercurrent illness with reduced oral intake, the infant develops lethargy. Laboratory testing shows low plasma ketones despite elevated free fatty acids.
Based on the experimental setup, what is the most likely effect of the deficiency on metabolism?
Explanation: This question tests understanding of carnitine's essential role in fatty acid oxidation. Carnitine is required for transporting long-chain fatty acyl groups across the inner mitochondrial membrane via the carnitine shuttle (CPT1 and CPT2 system). Without adequate carnitine, long-chain fatty acids cannot enter mitochondria for beta-oxidation, preventing acetyl-CoA generation and subsequent ketone body production during fasting, despite elevated free fatty acids in plasma. The correct answer A accurately describes this transport defect and its consequences. Choice B incorrectly places the defect in cytosolic transport, when the actual problem is mitochondrial entry for beta-oxidation. When evaluating metabolic defects, identify the specific transport or enzymatic step affected and trace the consequences.
A nutrition study cultures human hepatocytes in media lacking an essential amino acid (leucine) for 12 hours, then measures global protein synthesis via incorporation of labeled methionine. Compared with complete media, leucine-depleted cells show decreased labeled methionine incorporation and increased phosphorylation of eIF2b1. Intracellular triglyceride content increases modestly. Which outcome is most consistent with these observations regarding fatty acid and protein metabolism?
Explanation: This question tests understanding of amino acid sensing, protein synthesis regulation, and its effects on lipid metabolism. Leucine is an essential amino acid that serves as a nutrient signal for protein synthesis through the mTOR pathway. Leucine depletion activates stress responses including phosphorylation of eIF2α, which globally decreases translation initiation and protein synthesis, as shown by reduced methionine incorporation. When protein synthesis decreases, hepatocytes produce fewer apolipoproteins needed for VLDL assembly and secretion, causing triglycerides to accumulate intracellularly rather than being exported. Choice A is incorrect because leucine depletion decreases, not increases, translation initiation through stress signaling pathways. When analyzing metabolic stress responses, consider how changes in one pathway (protein synthesis) can indirectly affect another (lipid export).
Investigators examine insulin regulation of lipid handling in adipocytes. Cells are treated with insulin or vehicle for 30 minutes, then stimulated with epinephrine. In insulin-pretreated cells, phosphorylation of hormone-sensitive lipase (HSL) at the activating PKA site is reduced, and glycerol release into the medium is lower than vehicle-pretreated cells. What conclusion can be drawn about the role of insulin in fat storage?
Explanation: This question tests understanding of insulin's anti-lipolytic effects and the regulation of hormone-sensitive lipase (HSL). HSL catalyzes the rate-limiting step of lipolysis in adipocytes, and its activity is increased by PKA-mediated phosphorylation in response to catecholamines like epinephrine. Insulin antagonizes this process by activating phosphodiesterases that degrade cAMP and by activating protein phosphatases that dephosphorylate HSL, thereby reducing its activity. The experimental data shows that insulin pretreatment reduces PKA-mediated HSL phosphorylation and glycerol release (a marker of lipolysis), demonstrating insulin's role in promoting fat storage by inhibiting triglyceride breakdown. Choice A is incorrect because insulin opposes, rather than potentiates, catecholamine-stimulated lipolysis. When analyzing hormone interactions, consider how insulin's anabolic effects oppose catabolic signals.
A clinical research team studies a patient with exercise intolerance and episodic hypoketotic hypoglycemia during fasting. Sequencing identifies a missense mutation in the mitochondrial acyl-CoA dehydrogenase used for medium-chain fatty acids (MCAD). In cultured hepatocytes incubated with palmitate (C16:0) versus octanoate (C8:0), the following are observed after 6 hours: octanoate-treated mutant cells show lower oxygen consumption and lower acetoacetate release than wild-type, while palmitate-treated mutant cells are similar to wild-type. Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
Explanation: This question tests understanding of fatty acid metabolism and the role of medium-chain acyl-CoA dehydrogenase (MCAD) in β-oxidation. MCAD specifically catalyzes the first oxidation step of medium-chain fatty acids (6-12 carbons) in mitochondrial β-oxidation, while long-chain acyl-CoA dehydrogenase (LCAD) handles longer fatty acids like palmitate (C16). The experimental data shows that octanoate (C8, a medium-chain fatty acid) metabolism is impaired in mutant cells (lower oxygen consumption and acetoacetate production), while palmitate metabolism remains normal. Since MCAD deficiency prevents efficient β-oxidation of medium-chain fatty acids, less acetyl-CoA is generated from octanoate, resulting in reduced substrate for ketogenesis during fasting. Choice B is incorrect because β-oxidation occurs in mitochondria, not the cytosol, and MCAD deficiency would decrease, not increase, oxidation of medium-chain fatty acids. To approach similar problems, identify which specific enzyme is affected and match the substrate specificity to the experimental observations.
A biochemical genetics lab identifies a loss-of-function mutation in peroxisomal acyl-CoA oxidase 1 (ACOX1), an enzyme involved in very-long-chain fatty acid (VLCFA) oxidation. Patient fibroblasts accumulate VLCFAs, but mitochondrial oxygen consumption with palmitate is near normal. When cells are provided lignoceric acid (C24:0), mutant cells show minimal production of shorter-chain fatty acids compared with controls. Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
Explanation: This question tests understanding of peroxisomal fatty acid oxidation and its role in very-long-chain fatty acid (VLCFA) metabolism. Peroxisomes are specialized for oxidizing VLCFAs (>C20) through a process that shortens them to medium-chain fatty acids, which can then be completely oxidized in mitochondria. ACOX1 catalyzes the first step of peroxisomal β-oxidation, and its deficiency prevents the breakdown of VLCFAs like lignoceric acid (C24) into shorter chains. The observation that palmitate (C16) oxidation remains normal confirms that mitochondrial β-oxidation is intact, but the inability to shorten VLCFAs in peroxisomes prevents their subsequent mitochondrial oxidation. Choice B is incorrect because the defect is in peroxisomal, not mitochondrial, fatty acid processing, and the carnitine shuttle handles long-chain, not very-long-chain, fatty acids. To understand organelle-specific metabolism, recognize that peroxisomes and mitochondria have complementary roles in complete fatty acid oxidation.
A researcher engineers human myocytes to express a mutant carnitine palmitoyltransferase I (CPT1) with reduced affinity for carnitine but normal catalytic activity once carnitine is bound. When cells are switched from high glucose to low glucose media with palmitate as the main fuel, mutant cells show reduced oxygen consumption and accumulate cytosolic long-chain acyl-CoA compared with wild-type. Based on the experimental setup, what is the most likely effect of the mutation on metabolism?
Explanation: This question tests understanding of the carnitine shuttle system and its role in fatty acid metabolism. CPT1 catalyzes the rate-limiting step of fatty acid β-oxidation by converting long-chain acyl-CoA to acyl-carnitine for transport into mitochondria. The mutant CPT1 has reduced affinity for carnitine, meaning it requires higher carnitine concentrations to function normally. In low glucose conditions when cells rely on fatty acid oxidation, the mutant's impaired ability to bind carnitine prevents efficient transport of long-chain fatty acids into mitochondria, causing cytosolic accumulation of long-chain acyl-CoA and reduced oxygen consumption from decreased β-oxidation. Choice B is incorrect because the mutation impairs, not enhances, fatty acid entry into mitochondria. When analyzing metabolic mutations, consider how changes in substrate affinity affect enzyme function under physiological substrate concentrations.